INDUSTRY DEBATE Are large CRO operating models equipped to support the agility and priorities of small biotechs?

  • Navigating traditional and niche CRO models as an emerging biotech
  • Understanding the key differences between big pharma and biotech approaches to clinical trial execution and outsourcing strategy
  • Examining how niche and specialist vendors are addressing sponsor pain points with more tailored, flexible solutions
  • Identifying how sponsors and providers can better align expectations, communication models, and operational support for successful partnerships

INTERACTIVE SESSION Solution Sprint

  • Overview: Opportunities for vendor to address real-world biopharma specific challenges
  • How it runs: Audience/Advisory Board poses a challenge to 3 vendors, and they have to present their company’s solutions.
  • Best for: Sponsor opportunity and Biopharma /Vendor Interaction

Reserved for Event Sponsors

INTERACTIVE SESSION The Traps of AI: Misrepresentation, Bias, and the Limits of Existing Data

Opening Question

“If your AI is trained on incomplete data, who is it really working for – and who is it leaving behind?” 

Key Focus Areas

  • How reliance on historical datasets creates systemic gaps, leaving underrepresented groups without sufficient data to ensure accurate AI outputs
  • Exploring the real-world impact of misrepresentation through live audience polling and scenario-based discussions
  • Challenging assumptions: where do we overtrust AI, and how aware are organisations of its limitations?
  • Practical steps to improve outcomes, including how to identify bias and push for more inclusive, representative data

Format

This session will be highly interactive, using live polling, audience Q&A, and scenario-led discussion to test perceptions and uncover blind spots. Attendees will respond to real-world scenarios, compare perspectives across the room, and collectively explore how bias and data gaps influence decision-making in practice.

INTERACTIVE SESSION Solution Sprint

  • Overview: Opportunities for vendor to address real-world biopharma specific challenges
  • How it runs: Audience/Advisory Board poses a challenge to 3 vendors, and they have to present their company’s solutions.
  • Best for: Sponsor opportunity and Biopharma /Vendor Interaction

Reserved for Event Sponsors